Cargando…

Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program

OBJECTIVES: Interval colorectal cancer (CRC) after colonoscopy may affect effectiveness and cost-effectiveness of screening programmes. We aimed to investigate whether and how faecal haemoglobin concentration (FHbC) of faecal immunochemical testing (FIT) affected the risk prediction of interval canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiu, Sherry Yueh-Hsia, Chuang, Shu-Ling, Chen, Sam Li-Sheng, Yen, Amy Ming-Fang, Fann, Jean Ching-Yuan, Chang, Dun-Cheng, Lee, Yi-Chia, Wu, Ming-Shiang, Chou, Chu-Kuang, Hsu, Wen-Feng, Chiou, Shu-Ti, Chiu, Han-Mo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Colon
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284478/ https://www.ncbi.nlm.nih.gov/pubmed/26515543 http://dx.doi.org/10.1136/gutjnl-2015-310256

Ejemplares similares

Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers
por: Chiu, Han-Mo, et al.
Publicado: (2021)

Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme
por: Peng, Szu-Min, et al.
Publicado: (2021)

Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
por: Mowat, Craig, et al.
Publicado: (2016)

Elucidating bidirectional relationship between metabolic syndrome and elevated faecal haemoglobin concentration: a Taiwanese community-based cohort study
por: Ku, Mei-Sheng, et al.
Publicado: (2019)

Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer
por: Zorzi, Manuel, et al.
Publicado: (2022)

Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study
por: Cross, Amanda J, et al.
Publicado: (2019)

Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death
por: Chen, Li-Sheng, et al.
Publicado: (2013)

Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia
por: Wong, Sunny H, et al.
Publicado: (2017)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013)

Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model
por: Meester, Reinier G S, et al.
Publicado: (2023)

Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program
por: Chiu, Han-Mo, et al.
Publicado: (2015)

Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers
por: Lee, Yi-Chia, et al.
Publicado: (2017)

Results from a retrospective analysis of colonoscopies for Inflammatory bowel disease and colorectal cancer in a Lebanese tertiary care centre
por: Saber, Toufic, et al.
Publicado: (2017)

Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community‐based cohort study
por: Pin‐Vieito, Noel, et al.
Publicado: (2021)

Initial US evaluation of second-generation capsule colonoscopy for detecting colon polyps
por: Morgan, Douglas R, et al.
Publicado: (2016)

Low-residue breakfast during the preparation for colonoscopy using a polyethylene glycol electrolyte solution: a randomised non-inferiority trial
por: Flemming, Jennifer A, et al.
Publicado: (2015)

Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2023)

Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment
por: Wang, Feng, et al.
Publicado: (2022)

Genomic evolution and diverse models of systemic metastases in colorectal cancer
por: Chen, Hai-Ning, et al.
Publicado: (2022)

An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles
por: Bresalier, Robert S, et al.
Publicado: (2023)

Novel TCF21(high) pericyte subpopulation promotes colorectal cancer metastasis by remodelling perivascular matrix
por: Li, Xiaobo, et al.
Publicado: (2023)

Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme
por: Lo, Siu Hing, et al.
Publicado: (2015)

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
por: Møller, Pål, et al.
Publicado: (2017)

Colorectal cancer screening with odour material by canine scent detection
por: Sonoda, Hideto, et al.
Publicado: (2011)

MED12 is recurrently mutated in Middle Eastern colorectal cancer
por: Siraj, Abdul K, et al.
Publicado: (2018)

Genetic architectures of proximal and distal colorectal cancer are partly distinct
por: Huyghe, Jeroen R, et al.
Publicado: (2021)

TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres
por: Jones, A M, et al.
Publicado: (2011)

Performance measures in three rounds of the English bowel cancer screening pilot
por: Moss, S M, et al.
Publicado: (2011)

Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
por: Church, Timothy Robert, et al.
Publicado: (2014)

Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer
por: Yu, Jun, et al.
Publicado: (2015)

Occult blood in faeces is associated with all-cause and non-colorectal cancer mortality
por: Libby, Gillian, et al.
Publicado: (2018)

Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer
por: Amicarella, F, et al.
Publicado: (2017)

Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis
por: Roelands, Jessica, et al.
Publicado: (2023)

High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity
por: de Vries, Natasja L, et al.
Publicado: (2020)

Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years
por: Vuik, Fanny ER, et al.
Publicado: (2019)

Young-onset colorectal cancer risk among individuals with iron-deficiency anaemia and haematochezia
por: Demb, Joshua, et al.
Publicado: (2021)

T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes
por: Mennonna, Daniele, et al.
Publicado: (2017)

Squalene epoxidase drives cancer cell proliferation and promotes gut dysbiosis to accelerate colorectal carcinogenesis
por: Li, Chuangen, et al.
Publicado: (2022)

Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC)
por: Salvucci, Manuela, et al.
Publicado: (2022)

Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases
por: Sullivan, Kevin M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hh1l123lqn8eagka1vj0b7ljla